Skip to main content
. Author manuscript; available in PMC: 2024 Sep 18.
Published in final edited form as: ACS Appl Bio Mater. 2023 Aug 11;6(9):3912–3918. doi: 10.1021/acsabm.3c00574

Figure 4. VEGF-targeting siRNA-LSNAs inhibit angiogenesis in vitro.

Figure 4.

Optical microscope images of HUVECs grown in Matrigel basement membrane matrix following treatment with siRNA-LSNAs for 24 h and 48 h, scale bar: 50 μm. Yellow arrows indicate capillary-like tubes.